Welcome to the Homepage of DiePharmazie

DiePharmazie is a leading open access journal of pharmaceutical sciences covering all the areas of pharmacy. As a peer-reviewed scientific journal, DiePharmazie is regularly indexed in PubMed, PubPharm, Science Citation index, Clarivate Web of Science, Scopus, Embase, CA plus (Chemical Abstracts), and many others.

Call for Papers

The editors are inviting pharmaceutical scientists from all over the world to submit research papers of worldwide interest and high scientific quality.

Please read the instructions for authors.

Open Access

You can have a look at the contents of recent issues of DiePharmazie below, full texts can be found at the ingentaconnect platform.

In January 2020 onwards DiePharmazie turned into a full Open Access electronic Journal. There is an article processing fee of 500 € plus VAT for every article submitted.

Obituary Siegfried Pfeifer (1926–2021)

It is with great sadness that we heard that Prof. Dr. Siegfried Pfeifer passed away in Berlin on 13th July 2021, a few weeks after his 95th birthday. Professor Pfeifer served this journal for 32 years as editor-in-chief from 1961 to 1993. During this long period, PHARMAZIE continuously increased its reputation and achieved its present status of a peer reviewed international journal. It is the only specialist journal which has been founded in the German Soviet Occupation Zone (later German Democratic Republic, GDR) and is edited up to the present day. Thus, Professor Pfeifer truly wrote a success story in scientific publishing, being an outstanding and highly esteemed scientist himself as well, as a pharmaceutical chemist but also as a forerunner of biopharmaceutics, a completely new pharmaceutical discipline in the 1960s. Publisher and editors are commemorating him with extraordinary gratitude.

(for further details see Friedrich C, Helmstädter A (2020) Seventy-five volumes of PHARMAZIE – a historical review. PHARMAZIE 75: 289–293)

Editors

Prof. Dr. Theodor Dingermann, Frankfurt am Main, Editor-in-chief
Prof. Dr. Sandra Klein, Greifswald, Editor-in-chief
Prof. Dr. Axel Helmstädter, Marburg

Editors E-Mail

Contents of DiePharmazie

For abstracts, TOC alerts, and full text (for subscribers or on a pay-per-view basis) see:

http://www.ingentaconnect.com/content/govi/pharmaz

DiePharmazie 2021

DiePharmazie 2020

For any comment from your side, no matter if it is criticism, compliments or the pointing out of mistakes we made, we are very grateful; please e-mail to pharmazie@avoxa.de.

DiePharmazie 2019

For any comment from your side, no matter if it is criticism, compliments or the pointing out of mistakes we made, we are very grateful; please e-mail to pharmazie@avoxa.de.

DiePharmazie 2018

For any comment from your side, no matter if it is criticism, compliments or the pointing out of mistakes we made, we are very grateful; please e-mail to pharmazie@avoxa.de.